VRDN

Viridian Therapeutics, Inc. is a pioneering biopharmaceutical company based in Boulder, Colorado, specializing in the development of innovative therapies for rare and autoimmune disorders. The company is committed to leveraging advanced research and development to address significant unmet medical needs, with a robust pipeline of drug candidates poised to transform the therapeutic landscape. With a focus on enhancing patient outcomes, Viridian Therapeutics stands at the forefront of addressing the challenges associated with severe diseases, making it a key player in the biopharmaceutical sector.